The weekly litigation news digest is live. Subscribe now

IP Verse

Mdm2 Inhibitors And Combinations Thereof - EP3340989

The patent EP3340989 was granted to Novartis on Aug 16, 2023. The application was filed on Aug 24, 2016 under application number EP16760803A. The patent is currently recorded with a legal status of "Revoked".

EP3340989

NOVARTIS
Application Number
EP16760803A
Filing Date
Aug 24, 2016
Status
Revoked
Jun 13, 2025
Publication Date
Aug 16, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ELKINGTON AND FIFEMay 15, 2024ELKINGTON AND FIFEADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO0206213
DESCRIPTIONWO03077914
DESCRIPTIONWO2005121142
DESCRIPTIONWO2006122806
DESCRIPTIONWO2007044084
DESCRIPTIONWO2007084786
DESCRIPTIONWO2010029082
DESCRIPTIONWO2011076786
DESCRIPTIONWO2012066095
DESCRIPTIONWO2013111105
INTERNATIONAL-SEARCH-REPORTEP2752191
INTERNATIONAL-SEARCH-REPORTUS2013281473
INTERNATIONAL-SEARCH-REPORTWO2015070224
INTERNATIONAL-SEARCH-REPORTWO2015084804
OPPOSITIONEP2752191
OPPOSITIONUS2013281473
OPPOSITIONWO2013111105
OPPOSITIONWO2015070224
OPPOSITIONWO2015084804
OPPOSITIONWO2015097621

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents